The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Unicycive Therapeutics Inc (NASDAQ: UNCY) closed at $0.53 down -40.88% from its previous closing price of $0.90. In other words, the price has decreased by -$40.88 from its previous closing price. On the day, 49.41 million shares were traded.
Ratios:
For a deeper understanding of Unicycive Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on April 21, 2025, initiated with a Buy rating and assigned the stock a target price of $6.
Stock Price History:
Over the past 52 weeks, UNCY has reached a high of $1.10, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -12.60%, while the 200-Day Moving Average is calculated to be -5.17%.
Shares Statistics:
A total of 119.75M shares are outstanding, with a floating share count of 100.03M. Insiders hold about 17.08% of the company’s shares, while institutions hold 50.74% stake in the company.
